28,653 Spam-Free Article(s) Found
Article Searches
Yahoo! (YHOO) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/256544/yahoo-yhoo-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-256544 Apr 17, 2017 - Yahoo! Inc. (YHOO) is set to report first-quarter 2017 results on Apr 18 after the bell.
The 7 Most Tax-Friendly States https://www.fool.com/taxes/2017/04/17/the-7-most-tax-friendly-states.aspx?source=iedfolrf0000001 Apr 17, 2017 - Planning to relocate? Consider moving to one of the more tax-friendly states.
Can Philip Morris Keep Climbing Higher? https://www.fool.com/investing/2017/04/17/can-philip-morris-keep-climbing-higher.aspx?source=iedfolrf0000001 Apr 17, 2017 - Investors are looking for continued gains for both the tobacco giant's traditional cigarette business and for reduced-risk products.
3 Stocks that Could Lose You a Lot of Money https://www.fool.com/investing/2017/04/17/3-stocks-that-could-lose-you-a-lot-of-money.aspx?source=iedfolrf0000001 Apr 17, 2017 - These beleaguered oil stocks could go all the way to zero if conditions don’t dramatically improve.
Skechers Stock Has a Lot to Prove on Thursday https://www.fool.com/investing/2017/04/17/skechers-stock-has-a-lot-to-prove-on-thursday.aspx?source=iedfolrf0000001 Apr 17, 2017 - The leading walking footwear specialist reports quarterly results on Thursday. It's eyeing mixed results.
The Impressive Dividend History of Vanguard Dividend Appreciation ETF https://www.fool.com/investing/2017/04/17/impressive-history-vanguard-dividend-appreciation.aspx?source=iedfolrf0000001 Apr 17, 2017 - The exchange-traded fund has paid its investors well.
Can Hasbro Duplicate Marvel's Success in Creating a Cinematic Universe? https://www.fool.com/investing/2017/04/17/can-hasbro-duplicate-marvels-success-creating-a-ci.aspx?source=iedfolrf0000001 Apr 17, 2017 - Hasbro has ambitions to build its own cinematic universe, hoping to strike gold with decades-old animated characters. Sound familiar?
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001 Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
Report: Intel Corporation Preps 6-Core Coffee Lake for Launch in Q4 https://www.fool.com/investing/2017/04/17/report-intel-corporation-preps-six-core-coffee-lak.aspx?source=iedfolrf0000001 Apr 17, 2017 - Intel is planning new processors and related chipsets for the desktop market later this year, according to BenchLife.info.
Forget Solar Yieldcos: This Is a Better Way to Generate a Renewable Income Stream https://www.fool.com/investing/2017/04/17/forget-solar-yieldcos-this-is-a-better-way-to-gene.aspx?source=iedfolrf0000001 Apr 17, 2017 - With a rock-solid balance sheet and a clearly visible growth profile, this renewable MLP is a better investment for investors looking to add a clean energy cash flow stream to their portfolio.
<<<Page 2806>